Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers. (pnas.org)

Authors: Tendler S … Lewis JS Journal: PNAS Published: 2026-02-10 DOI: https://doi.org/10.1073/pnas.2505785123